Floship-FedEx Collaboration To Provide E-tailers With Enhanced Fulfilment, Logistics Services

KUALA LUMPUR, June 14 (Bernama) -- Floship, a global circular supply chains solutions provider for e-commerce brands, and FedEx Corp announced a partnership designed to provide enhanced fulfilment and logistics services to e-tailers worldwide.

According to a statement, through investment by the FedEx Innovation Lab (FIL), the partnership will create an end-to-end digitalised fulfilment and return solution, enhancing operational efficiency via optimal inventory management and best-in-class delivery using FedEx services.

“By bringing this collaboration to market, our mutual goal is to provide e-commerce brands and retailers with a one-stop, all-inclusive two-way supply chain solution that enables brands to grow at an exponential rate whilst simultaneously delivering a superior customer experience,” said Floship chief executive officer, Joshua Tsui.

Meanwhile, FedEx Express senior vice president, Marketing and Customer Experience for Asia Pacific, Middle East and Africa (AMEA) region, Salil Chari said collaborating with industry innovators like Floship will help online retailers better compete supported by the FedEx global logistics network.

This partnership will give FedEx’s e-commerce customers access to Floship’s global network of warehouses and powerful logistics platform’s capabilities to streamline their e-commerce fulfilment operations.

At the same time, Floship’s customers will be able to leverage FedEx global networks as well as a full range of FedEx extensive transportation options to optimise their operations.

Additionally, FedEx’s and Floship’s cross-border e-commerce customers in AMEA, Europe, and North America will gain access to enhanced fulfilment, last-mile delivery as well as hassle-free returns.

The FIL makes early-stage investments in rising start-ups primarily in India. These collaborations will bring additional value in terms of capabilities and speed to market to start-up firms through FedEx’s global networks, resources and customer base.

The collaborations will also help expand FedEx advanced digital capabilities globally as it continues to evolve its operations and product offerings to meet the needs of the modern supply chain.

-- BERNAMA

BABY HEALTH CARE RECOGNIZED AS ONE OF THE TOP 10 FETAL AND NEONATAL CARE COMPANIES OF 2023 BY MEDTECH OUTLOOK

 

MedTech Outlook provides a platform for decision-makers and experts to share their views on medical technologies that have significantly impacted healthcare delivery. (Graphic: Business Wire)

 

NEWPORT BEACH, Calif., June 13 (Bernama-BUSINESS WIRE) -- Baby Health Care is proud to announce that it has been recognized as one of the Top 10 Fetal and Neonatal Care Companies for 2023 by MEDTECH OUTLOOK, a globally renowned medical publication that spotlights trailblazing solutions reshaping contemporary healthcare.
 

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230531005595/en/  

The recognition is a testament to our unwavering commitment and innovation in pediatric healthcare, particularly exemplified through our pioneering electric nasal aspirator.

Our CEO, Kiyotaka Yamafuji, affirms, "We believe minimal medication is ideal for better health, and it is our product goal too. It eliminates the need for medication when it comes to nasal congestion in babies." The company takes immense pride in this recognition. The belief that the cornerstone of a child's growth and health is shaped by proper care, coupled with accurate knowledge and affection at home, guides the development and innovation of our products.

Our electric nasal aspirator stands as a prime example of our company philosophy. It offers a highly efficient solution to suction nasal mucus. Though simple in design, it provides numerous benefits. By streamlining the process of nasal cleaning compared to manual methods, it reduces the risk of middle ear infections and other illnesses, while enhancing the sleep quality of infants. 

http://mrem.bernama.com/viewsm.php?idm=46339

MCO REINFORCES COMMITMENT PROVIDING CUTTING-EDGE SOLUTIONS VIA FAIRWORDS ACQUISITION

KUALA LUMPUR, June 13 (Bernama) -- MyComplianceOffice Inc (MCO), a conduct risk and compliance technology provider, announced the acquisition of Fairwords, a pioneer in artificial intelligence (AI)-powered electronic communications software.

According to MCO in a statement, the acquisition reinforces its commitment to providing cutting-edge solutions that enable organisations to effectively manage compliance.

By integrating Fairwords' AI-powered communications protection software into its comprehensive suite of offerings, MCO solidifies its position as a leader in the global compliance technology market.

“With this acquisition, we will further augment our solution for exceptional integrated surveillance capability across all transactions, employees and third-party entities. We are thrilled to welcome Fairwords, its talented team and customers to the MCO family,” said MCO Chief Executive Officer (CEO), Brian Fahey.

Meanwhile, Fairwords CEO, Tom Bubeck said: “Throughout the due diligence process, we concluded that MCO's dedication and investment in the surveillance space make it the ideal home for our team and clients. I have no doubt that our customers will be extremely satisfied with MCO for many years to come.”

Fairwords' communications compliance software provides compliance leaders and teams with proactive training, analytics, and archiving to mitigate communications risks and prevent compliance crises and lawsuits.

The software also provides firms with a streamlined solution for monitoring and flagging risky communications, while ensuring the archival of digital messages in compliance with regulatory requirements.

The acquisition will expand MCO's integrated surveillance solution to encompass digital communications, thus strengthening its ability to identify potential compliance issues.

In addition, it will enhance MCO customers' ability to ensure communications compliance across various channels while fostering a robust culture of compliance within their organisations.

-- BERNAMA

Cohere Secures Us$270 Mln Funding To Empower Businesses With Generative Ai

KUALA LUMPUR, June 9 (Bernama) -- Cohere, the leading artificial intelligence (AI) platform for enterprise, announced US$270 million in new capital as part of its Series C financing. (US$1=RM4.60)

Inovia Capital led the round, with additional participation from a diverse group of global institutional and strategic investors, including NVIDIA, Oracle, Salesforce Ventures, DTCP, Mirae Asset, Schroders Capital, SentinelOne, Thomvest Ventures, and returning investor Index Ventures, some of the most respected technology companies in the world.

“As the early excitement about generative AI shifts toward ways to accelerate businesses, companies are looking to Cohere to position them for success in a new era of technology.

“The next phase of AI products and services will revolutionise business, and we are ready to lead the way,” said Cohere chief executive officer and co-founder, Aidan Gomez in a statement.

Cohere’s AI platform is uniquely designed for enterprises, offering data-secure deployment options in companies’ existing cloud environments, customisation and customer support, including an ecosystem of consulting and system integrator partners to help enterprises at any stage in their AI journey.

Cohere’s enterprise AI suite is cloud-agnostic, offering the highest levels of flexibility and data privacy. It is built to be available on every cloud provider, deployed inside a customers’ existing cloud environment, virtual private cloud (VPC), or even on-site, to meet companies where their data is.

This is to empower businesses to transform existing products and build the next era-defining generation of innovative solutions all while keeping their data secure.

The announcement comes on the heels of Cohere’s momentum in several areas, namely a recent announcement to collaborate with Salesforce Ventures to advance generative AI to realise business value; an engagement with LivePerson to supercharge customer experiences; and a host of additional demand and interest from the enterprise market.

-- BERNAMA

DUCK CREEK'S RATING SOLUTIONS EARN CELENT’S LUMINARY STATUS IN NORTH AMERICA, GLOBALLY

KUALA LUMPUR, June 9 (Bernama) -- Duck Creek Technologies, has received Luminary status in Celent’s 2023 North America and global reports, Insurer Stand-Alone Rating Engines.

An intelligent solutions provider defining the future of Property and Casualty (P&C) and general insurance, Duck Creek’s rating solutions have been recognised in the report’s highest-ranking category for advanced technology and breadth of functionality.

Duck Creek Technologies Chief Product & Technology Officer, Jess Keeney said the company is proud to continue to earn Celent’s highest Luminary ranking in North America and globally for its rating solutions.

“We are continuously seeking ways to modernise our technology and create evergreen solutions that cultivate a better user experience for our customers. Deploying frequent, fully automated updates with configurability enables us to do this,” she said in a statement.

This report provides an overview of Duck Creek Rating, which enables customers to rate 583,000 quotes per hour/per server of complex personal lines policies in a 100 per cent horizontally scalable manner.

In North America and across the globe, Duck Creek maintains an open platform and open ecosystem philosophy, offering over 100 pre-built and validated integration accelerators. This includes Duck Creek Rating Anywhere Integrations with Coherent, Akur8, AAIS and Verisk.

Celent’s report profiles key stand-alone rating engines and provides an overview of their functionality and technology, in which the report equips P&C insurance carriers with the knowledge and insights to evaluate the market’s best stand-alone rating engines for their business.

Celent is a research and advisory firm dedicated to helping financial institutions formulate comprehensive business and technology strategies.

-- BERNAMA

MedTech Innovator Asia Pacific Names 24 Startups to Annual Accelerator

LOS ANGELES & SINGAPORE, June 8 (BUSINESS WIRE) --

MedTech Innovator, the world’s largest accelerator of medical technology companies announced today that 24 medtech companies will participate in the fourth annual Asia Pacific Accelerator program.

MedTech Innovator Asia Pacific offers best-in-class startups opportunities to work with investors, business leaders and allied service professionals in the medtech industry to help drive commercialization of life-changing technologies throughout the region. The 2023 cohort companies will also compete for up to US$ 300,000 in cash prizes and awards.

“As the world’s largest accelerator of medtech companies, MedTech Innovator established the Asia Pacific Program in 2019 because of the incredible innovation in the region. We look forward to working with our partners to support this year’s cohort of companies and to help them advance their technologies,” said Paul Grand, CEO of MedTech Innovator.

Over 400 companies applied for the Asia Pacific program this year, and after a rigorous selection process, 60 companies were invited to pitch, 24 of which were named to the 2023 cohort. In early December, four startups from the 2023 Asia Pacific cohort will advance to compete in the Grand Finals to be held at APACMed’s Medtech Forum 2023 in Singapore. Attended by health care industry leaders, health care providers, and investors from across the region, the MedTech Forum will also showcase solutions from all 24 Accelerator cohort companies. The winning company, which will be determined by audience vote, stands to win a non-dilutive cash prize and the title of the 2023 MedTech Innovator Asia Pacific Winner.

For the first time, MedTech Innovator Asia Pacific’s 2023 cohort will include four shortlisted companies that are part of the inaugural Olympus Asia Pacific Innovation Program (OAIP). This program focuses on minimally invasive care and new ways to detect, monitor, and treat conditions and diseases. The winning innovator will receive grant funding of US$ 75,000 as well as an exclusive mentorship program with key thought leaders from within Olympus.

The 24 companies selected to the 2023 MedTech Innovator Asia Pacific Accelerator are:

1. Accuster Technologies (India)
2. Astron Medtech (US)
3. Biotome (Australia)
4. Flexperc Medical (US)
5. Gbrain (South Korea)
6. GenLight Medical (China)
7. Healium Medical (Israel)
8. Jdot (Changzhou) Medical Technology (China)
9. Kinexcs (Singapore)
10. Lifespans (Hong Kong, China)
11. Medipixel (South Korea)
12. MedySapiens (South Korea)
13. Module Innovations (India)
14. Neurowyzr (Singapore)
15. NICE Surgical Solutions (Singapore)
16. Ossfila Technology (Hong Kong, China)
17. PrimaNova Technologies (Hong Kong, China)
18. Thrixen (Singapore)
19. Vivo Surgical (Singapore)
20. Weinnovate Biosolutions (India)

The companies shortlisted for the OAIP are:

1. BioCliq (India)
2. NDR Medical (Singapore)
3. Sonire Therapeutics (Japan)
4. Vesica Corporation (US)

MedTech Innovator’s 2023 Asia Pacific program sponsors include Johnson & Johnson, Olympus, Teleflex, Siemens Healthineers, B Braun Medical, Cambridge Consultants, JABIL Healthcare and Enterprise Singapore. The MedTech Innovator Asia Pacific Program is held in partnership with APACMed.

About MedTech Innovator

Based in Los Angeles, MedTech Innovator is the world’s largest accelerator of medical technology companies and the premier nonprofit startup accelerator in the medical technology industry. Its mission is to improve the lives of patients by accelerating the growth of companies that are transforming the healthcare system. Since 2013, MedTech Innovator has reviewed more than 9,000 startups and graduated 509 companies that have gone on to raise more than $6.8 billion in follow-on funding.

MedTech Innovator works closely with stakeholders across the industry to promote the growth of early and mid-stage startups. In collaboration with 35 corporate partners, as well as a broader network of more than 1,000 industry executives including investors, business development representatives, and other stakeholders, MedTech Innovator provides startups with individualized mentorship and feedback, funding opportunities, and continual engagement with peers and advisors.

For more information about MedTech Innovator, visit the website, and follow them on LinkedIn and Twitter. Follow MedTech Innovator Asia Pacific on LinkedIn.

About Asia Pacific Medical Technology Association (APACMed)

Founded in 2014 and headquartered in Singapore, APACMed represents manufacturers and suppliers of medical equipment, devices and in vitro diagnostics, industry associations and other key stakeholders associated with the medical technology industry in Asia Pacific.

Providing a unified voice for the medical devices and in-vitro diagnostics industry in Asia Pacific, APACMed works proactively with bilateral, regional and local government bodies to shape policies, demonstrate the value of medical technology and promote regulatory harmonization. We strive to promote digital health innovation and impact policy that advances healthcare access for patients by engaging with medical device associations and companies in Asia Pacific.

APACMed is also host to the annual Asia Pacific MedTech Forum. www.apacmed.org

Contact

Joe Duraes
Pazanga Health Communications
jduraes@pazangahealth.com
(917) 687-6419

Source : MedTech Innovator

 

ECI HIRES JEFF SCHMIDT AS CEO TO LEAD NEXT PHASE OF GROWTH

KUALA LUMPUR, June 7 (Bernama) -- ECI, the leader in managed services and cybersecurity for the global financial services industry, has appointed Jeff Schmidt as president and chief executive officer (CEO).

According to a statement, outgoing CEO of ECI, David Andrade will consult with Schmidt and the company during a transition period.

“I personally thank David for nearly two decades of exemplary service, including the past three years as CEO. David's contributions have helped build ECI into the powerful firm it is today and underpin the strong relationships and trust we enjoy with our clients and partners,” said Executive Chairman of ECI's Board of Directors, John Cahaly.

Schmidt is a leader in managed services, technology, and cybersecurity with a long track record of growing sales, increasing profits, managing complex acquisitions and integrations, building world-class teams, and boosting customer service and retention.

He joins ECI as the firm embarks on a new stage of growth to further secure its dominant role in the sector.

Meanwhile, Schmidt said: “ECI has more than two decades of experience solving its customers’ toughest challenges and helping them adopt new technology in an ever-changing environment.

“We will continue to answer the call from our customers and uphold our mission to be the most transformative business partner you will ever engage, as we grow our product offerings and expand our services into adjacent sectors.”

Most recently, Schmidt was the founding CEO of Avertium, a leading provider of cybersecurity services, where he tripled revenues over five years. Earlier, he held management positions of increasing responsibility at SQS, All Covered, and British Telecom.

-- BERNAMA